These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14135439)

  • 41. Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.
    Abramson HA; Rolo A
    J Asthma Res; 1965 Sep; 3(1):81-96. PubMed ID: 5318626
    [No Abstract]   [Full Text] [Related]  

  • 42. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 43. [First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects].
    SICUTERI F
    Prog Med (Napoli); 1960 Jan; 16():20-2. PubMed ID: 14446409
    [No Abstract]   [Full Text] [Related]  

  • 44. THE OTOLARYNGOLOGIST AND THE COMMON HEADACHE SYNDROMES.
    OSTFELD AM
    Trans Am Acad Ophthalmol Otolaryngol; 1963; 67():766-9. PubMed ID: 14082486
    [No Abstract]   [Full Text] [Related]  

  • 45. CHEMICAL PSYCHOSES.
    HOLLISTER LE
    Annu Rev Med; 1964; 15():203-14. PubMed ID: 14133845
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].
    JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C
    Encephale; 1964; 53():520-35. PubMed ID: 14222727
    [No Abstract]   [Full Text] [Related]  

  • 48. SEROTONIN BINDING TO NERVE-ENDING PARTICLES OF THE RAT BRAIN AND ITS INHIBITION BY LYSERGIC ACID DIETHYLAMIDE.
    MARCHBANKS RM; ROSENBLATT F; O'BRIEN RD
    Science; 1964 May; 144(3622):1135-6. PubMed ID: 14148433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the specificity of a cat behavior model for the study of hallucinogens.
    Marini JL; Sheard MH
    Eur J Pharmacol; 1981 Apr; 70(4):479-87. PubMed ID: 7238573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. THE FIGURAL AFTER-EFFECT AND LYSERGIC ACID DIETHYLAMIDE (LSD-25).
    KELM H; JENSEN SE; RAMSAY RW
    J Nerv Ment Dis; 1963 Dec; 137():557-60. PubMed ID: 14087675
    [No Abstract]   [Full Text] [Related]  

  • 52. [A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].
    MIYOSHI A
    Seishin Shinkeigaku Zasshi; 1964 Oct; 66():826-36. PubMed ID: 14286595
    [No Abstract]   [Full Text] [Related]  

  • 53. TOLERANCE TO LSD-25 IN SCHIZOPHRENIC SUBJECTS; ATTENUATION OF EFFECTS ON PUPILLARY DIAMETER AND KNEEJERK THRESHOLD AFTER CHRONIC INTOXICATION.
    CHESSICK RD; HAERTZEN CA; WIKLER A
    Arch Gen Psychiatry; 1964 Jun; 10():653-8. PubMed ID: 14159265
    [No Abstract]   [Full Text] [Related]  

  • 54. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 55. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blockade of depressor responses to serotonin and tryptamine by lysergic acid derivatives in the chicken.
    BUNAG RD; WALASZEK EJ
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():142-51. PubMed ID: 13874645
    [No Abstract]   [Full Text] [Related]  

  • 57. ANTI-SEROTONIN ACTIVITY AND CLINICAL TRANQUILIZATION.
    GALLANT DM; BISHOP MP; STEELE CA; NOBLIN CD
    J Neuropsychiatr; 1964 Jun; 5():273-8. PubMed ID: 14171300
    [No Abstract]   [Full Text] [Related]  

  • 58. FEATURES OF EXPERIMENTAL NEUROSIS PRODUCED BY LYSERGIC ACID DIETHYLAMINE.
    IVANOVA RA; LARICHEVA KA; MILSHTEIN GI
    Fed Proc Transl Suppl; 1964; 23():268-71. PubMed ID: 14145650
    [No Abstract]   [Full Text] [Related]  

  • 59. Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
    SICUTERI F; MICHELACCI S; FRANCHI G
    Int Arch Allergy Appl Immunol; 1959; 15():291-9. PubMed ID: 14446403
    [No Abstract]   [Full Text] [Related]  

  • 60. [Blocking of the action of tryptaminic substances on smooth musculature by 1-methyl-lysergic acid butanolamide: UML 491].
    SOLLERO L; KURTZ GS
    Hospital (Rio J); 1962 Jul; 62():1-11. PubMed ID: 13914968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.